Glutathione in HIV-Associated Neurocognitive Disorders
Current Issues in Molecular Biology · 31.05.2024 · 46 (6) · 5530-5549
DOI: 10.3390/cimb46060330 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 31.05.2024. Verfasst von Thomas Erdos und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH-NHLBI.
Abstract (Originalsprache)
A large portion of patients with Human Immunodeficiency Virus (HIV) have neurologic sequelae. Those with better-controlled HIV via antiretroviral therapies generally have less severe neurologic symptoms. However, for many patients, antiretrovirals do not adequately resolve symptoms. Since much of the pathogenesis of HIV/AIDS (Autoimmune Deficiency Syndrome) involves oxidative stress either directly, through viral interaction, or indirectly, through inflammatory mechanisms, we have reviewed relevant trials of glutathione supplementation in each of the HIV-associated neurocognitive diseases and have found disease-specific results. For diseases for which trials have not been completed, predicted responses to glutathione supplementation are made based on relevant mechanisms seen in the literature. It is not sufficient to conclude that all HIV-associated neurocognitive disorders (HAND) will benefit from the antioxidant effects of glutathione supplementation. The potential effects of glutathione supplementation in patients with HAND are likely to differ based on the specific HIV-associated neurocognitive disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.
ORCID-Profile: Thomas Erdos, Mika Masuda, Vishwanath Venketaraman
Förderung
- NHLBI NIH HHS
- NIH-NHLBI
Zitieren
APA
Erdos, T., Masuda, M., & Venketaraman, V. (2024). Glutathione in HIV-Associated Neurocognitive Disorders. Current Issues in Molecular Biology, 46(6), 5530-5549. https://doi.org/10.3390/cimb46060330
Vancouver
Erdos T, Masuda M, Venketaraman V. Glutathione in HIV-Associated Neurocognitive Disorders. Current Issues in Molecular Biology. 2024;46(6):5530-5549. doi:10.3390/cimb46060330
BibTeX
@article{Erdos2024,
author = {Erdos, Thomas and Masuda, Mika and Venketaraman, Vishwanath},
title = {Glutathione in HIV-Associated Neurocognitive Disorders},
journal = {Current Issues in Molecular Biology},
year = {2024},
volume = {46},
number = {6},
pages = {5530--5549},
doi = {10.3390/cimb46060330}
}
EUVIMED